Ads
related to: mrna stock priceget.dtitrader.com has been visited by 10K+ users in the past month
Search results
The Moderna News That Has MRNA Stock Price Surging This Week: 3 Key Catalysts
InvestorPlace· 3 days agoModerna (NASDAQ:MRNA) stock is up more than 20% in just the past five trading sessions as investors foresee strong growth opportunities for the biotechnology ...
Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 43% Discount?
Simply Wall St. via Yahoo Finance· 22 hours ago(NASDAQ:MRNA) from its intrinsic value? Using the most recent financial data, we'll take a look at...
Moderna Inc [NASDAQ: MRNA] Sees Increase in Stock Value – Knox Daily
Knox Daily· 2 days agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Moderna Inc shares valued at $1,912,350 were sold by Hoge...published ...
Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Up 5.8%
ETF DAILY NEWS· 2 days agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) shares were up 5.8% during trading on Wednesday . The company traded as high as $31.59 and last traded at $31.59. Approximately ...
Moderna director Afeyan sells over $2.3 million in company stock By Investing.com
Investing.com· 2 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a portion of his holdings in the...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 4 days agoShares of vaccine producers' stocks are trading higher Wednesday on reports indicating disease...
Robeco Institutional Asset Management B.V. Decreases Stake in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days ago(NASDAQ:MRNA – Free Report) by 51.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 68,889 shares of the company’s < ...
Selling US$3.3m Of Moderna Stock Rewarded Insiders
Simply Wall St. via Yahoo Finance· 5 days agoModerna, Inc.'s (NASDAQ:MRNA) stock rose 12% last week, but insiders who sold US$3.3m worth of stock over the last year are probably ...
Arcturus Therapeutics’ (ARCT) Outperform Rating Reaffirmed at William Blair
ETF DAILY NEWS· 2 days agoCanaccord Genuity Group lowered their target price on shares of Arcturus Therapeutics from $87.00 to $86.00 and set a buy rating on the stock in a report ...
Moderna Options Trading: A Deep Dive into Market Sentiment - Moderna (NASDAQ:MRNA)
Benzinga· 3 days agoWe aim to explore its current performance. Moderna's Current Market Status With a volume of 1,393,780, the price of MRNA is down -2.28% at $159.61. RSI ...